EMV 1.00% $2.02 emvision medical devices ltd

Ann: Portable Brain Scanner Delivered to First Clinical Site, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 970 Posts.
    lightbulb Created with Sketch. 529
    https://hotcopper.com.au/data/attachments/4871/4871986-1c6ac4d7e0656bde4c22aceef4024ff5.jpg

    Couple more days left in November. Expecting the update to be released this week around:
    - any feedback from "operator training" at Liverpool's biomedical engineering department
    - receipt of administrative "green light" to commence scanning

    - See video below giving a clear information of what are next steps in clinical trails some update, e.g. independent ethics committee , role to review trail and highest ethics standards are applied, they need to salsify benefits outweigh the risk.

    Some more information on the team I think that are behind the clinical trails at Liverpool (correct me if I'm wrong). CEO is Darryl Harkness https://www.linkedin.com/in/darryl-harkness-5393945/
    https://inghaminstitute.org.au/clinical-trials-2/

    https://hotcopper.com.au/data/attachments/4872/4872049-4a744e3aac36598f967d37aef5208d6b.jpg

 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.